SEOUL PHARMA CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,405 KRW | +1.04% |
|
+2.56% | -11.10% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2008 | 24.75B 18.27M 1.52B | Sales 2009 | 31.81B 23.48M 1.96B | Capitalization | 17.06B 12.59M 1.05B |
|---|---|---|---|---|---|
| Net income 2008 | 542M 400K 33.32M | Net income 2009 | 1.18B 872K 72.61M | EV / Sales 2008 | 0.51 x |
| Net Debt 2008 | 4.12B 3.04M 253M | Net Debt 2009 | 9.21B 6.8M 566M | EV / Sales 2009 | 0.83 x |
| P/E ratio 2008 |
15.7
x | P/E ratio 2009 |
14.4
x | Employees | 172 |
| Yield 2008 * |
-
| Yield 2009 |
1.47% | Free-Float | 40.59% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.04% | ||
| 1 week | +2.56% | ||
| Current month | +1.04% | ||
| 1 month | -2.71% | ||
| 3 months | -3.81% | ||
| 6 months | -6.71% | ||
| Current year | -11.10% |
1 week
3 335.00
3 405.00
1 month
3 230.003 555.00
Current year
3 230.003 915.00
1 year
3 230.004 565.00
3 years
3 230.0012 250.00
5 years
3 230.0016 000.00
10 years
3 230.0027 800.00
| Managers | Title | Age | Since |
|---|---|---|---|
Dong-Hyun Yoon
CEO | Chief Executive Officer | 49 | - |
Bong-Hwan Shin
CEO | Chief Executive Officer | 66 | - |
Se-Young Lee
DFI | Director of Finance/CFO | 54 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hee-Yeon Hwang
BRD | Director/Board Member | 52 | - |
Dong-Hyun Yoon
CEO | Chief Executive Officer | 49 | - |
Myung-Ki Son
BRD | Director/Board Member | 44 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 3,405 | +1.04% | 1,692 |
| 02/24/02 | 3,370 | 0.00% | 9,121 |
| 30/24/30 | 3,370 | +0.30% | 7,286 |
| 29/24/29 | 3,360 | +1.20% | 10,880 |
End-of-day quote Korea S.E., May 03, 2024
More quotes
Seoul Pharma Co Ltd is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Companyâs main products portfolio consists of drugs for cardio-vascular system, respiratory system and digestive system, antidiabetic drugs, anti-obesity drugs, antipyretic drugs, analgesic drugs, anti-inflammatory drugs, antibiotics, antibacterials, antifungal drugs, antiviral drugs, tonics, vitamins, minerals, creams, dugs for hypertension, antipyretics, drugs for skin disease, dugs for cough and phlegm redution, as well as ointments, among others. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
14/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -11.10% | 29.3M | |
| +19.98% | 43.48B | |
| +20.67% | 22.65B | |
| +14.56% | 14.73B | |
| +14.32% | 13.79B | |
| +44.72% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B |
- Stock Market
- Equities
- A018680 Stock